Decision Aids for Patients With Nonvalvular Chronic Atrial Fibrillation (DA4AFib)

The researchers are observing subject and clinician interaction in order to develop future education materials that will help patients and clinicians discuss atrial fibrillation and options to treat it.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Must be 18 or older
Must have an appointment for Atrial Fibrillation
Must not have dementia
Must not have severe hearing or vision impairment Patients will be given a written consent Guests that accompany patients will be given an oral consent KER unit PAG members will be given an oral consent

Treatment and study plan

feedback

Other

Study team members will conduct interviews with subjects to gather feedback on Atrial Fibrillation experiences

Primary outcomes

Interview Process

Time frame: baseline

The number of subjects to complete the interview process

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Collaborators

American Heart Association

Registry information

Acronym: (DA4AFib)

Important dates

Study start: 2018
Primary completion: 2020
Study completion: 2020
First posted: Nov 19, 2018
Registry last updated: Jan 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed